|
Issue |
Title |
|
Vol 17, No 2 (2025) |
The brain-computer interface in the recovery of upper limb motor function after stroke |
Abstract
PDF (Rus)
|
M. Yu. Pankov, E. V. Kostenko, L. V. Petrova, M. S. Filippov |
|
Vol 17, No 2 (2025) |
Rational approach to migraine attacks relief |
Abstract
PDF (Rus)
|
G. R. Tabeeva |
|
Vol 17, No 2 (2025) |
Cognitive impairment in depression and cerebrovascular disease |
Abstract
PDF (Rus)
|
I. V. Reverchuk |
|
Vol 17, No 1 (2025) |
Contribution of genomic variation to the severity of multiple sclerosis |
Abstract
PDF (Rus)
|
O. G. Kulakova, N. A. Matveeva, I. S. Kiselev, A. N. Boyko, O. O. Favorova |
|
Vol 17, No 1 (2025) |
Social frailty and cognitive impairment in elderly people |
Abstract
PDF (Rus)
|
Yu. K. Komleva, A. B. Salmina, N. A. Kolotyeva, K. A. Shpiliukova, N. I. Bondar, S. N. Illarioshkin, M. A. Piradov |
|
Vol 17, No 1 (2025) |
Tenoxicam. Pharmacological and clinical profile |
Abstract
PDF (Rus)
|
V. V. Afanasyev, D. A. Iskra |
|
Vol 17, No 1 (2025) |
A new representative of the group of non-steroidal anti-inflammatory drugs in the therapeutic arsenal of a Russian doctor: pelubiprofen |
Abstract
PDF (Rus)
|
A. E. Karateev |
|
Vol 16, No 6 (2024) |
Comorbid disorders and their possible prevention in patients with vestibular vertigo |
Abstract
PDF (Rus)
|
O. V. Kosivtsova, Yu. A. Starchina, B. A. Shoev |
|
Vol 16, No 6 (2024) |
Management of patients with cognitive impairment in old age |
Abstract
PDF (Rus)
|
D. A. Grishina, A. B. Lokshina, E. A. Sokolov |
|
Vol 16, No 6 (2024) |
Characteristics of the parent-child relationship in families of children with cerebral palsy and multiple sclerosis (literature review) |
Abstract
PDF (Rus)
|
E. A. Boiko, V. L Malygin, E. I. Glushchenko |
|
Vol 16, No 6 (2024) |
Vitamins and other nutrients that support nitric oxide homeostasis and counteract the development of endotheliopathy |
Abstract
PDF (Rus)
|
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, L. A. Mayorova |
|
Vol 16, No 6 (2024) |
Pain and cognitive functions – the battle for cognitive reserve |
Abstract
PDF (Rus)
|
L. T. Akhmedzhanova, G. R. Tabeeva, E. V. Mandra |
|
Vol 16, No 6 (2024) |
Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy |
Abstract
PDF (Rus)
|
D. V. Zakharov, D. D. Kokareva |
|
Vol 16, No 5 (2024) |
Gidazepam – daytime tranquilizer for the treatment of anxiety |
Abstract
PDF (Rus)
|
Yu. E. Azimova, D. S. Petelin |
|
Vol 16, No 5 (2024) |
Thoracalgia: diagnostic and treatment algorithms |
Abstract
PDF (Rus)
|
L. T. Akhmedzhanova, O. A. Solokha, V. G. Kukava |
|
Vol 16, No 5 (2024) |
Muscle relaxers in acute musculoskeletal back pain |
Abstract
PDF (Rus)
|
A. Kh. Mukhametzyanova, A. I. Isaikin |
|
Vol 16, No 5 (2024) |
An Exploration of Locomotor Syndrome among Geriatric Population – A Narrative Review |
Abstract
PDF (Eng)
|
K. Shanmuganathan, S. Kalpana, J. S. Sundar, S. Valarmathi, G. Srinivas |
|
Vol 16, No 4 (2024) |
Malingering and functional movement disorder |
Abstract
PDF (Rus)
|
K. M. Evdokimov, E. Yu. Fedotova, S. N. Illarioshkin |
|
Vol 16, No 4 (2024) |
Aviandr is a new original drug for treating anxiety |
Abstract
PDF (Rus)
|
V. A. Parfenov |
|
Vol 16, No 4 (2024) |
Agomelatine: pharmacological profile, possible application, advantages |
Abstract
PDF (Rus)
|
V. E. Medvedev, O. V. Kotova, A. V. Palin, O. V. Mikheeva, E. S. Akarachkova |
|
Vol 16, No 4 (2024) |
Ten rules for oral anticoagulants prescription after a stroke |
Abstract
PDF (Rus)
PDF (Eng)
|
A. A. Kulesh, D. A. Demin, S. S. Kucherenko |
|
Vol 16, No 3 (2024) |
Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem) |
Abstract
PDF (Rus)
|
Kh. I. Alizade, A. A. Ragimova, E. Yu. Fedotova, S. N. Illarioshkin |
|
Vol 16, No 3 (2024) |
Treatment of the early stages of Parkinson's disease. Differences in approaches to the choice of therapy in different countries |
Abstract
PDF (Rus)
|
E. V. Bril, N. V. Fedorova, T. K. Kulua, O. S. Zimnyakova |
|
Vol 16, No 3 (2024) |
Lipoprotein(a) as a risk factor for cardiovascular diseases - focus on ischemic stroke (a position paper) |
Abstract
PDF (Rus)
|
Ia. B. Skiba, A. Yu. Polushin, E. S. Saganova, A. S. Sokolov, E. A. Polyakova, S. N. Yanishevskiy, I. A. Vosnyuk |
|
Vol 16, No 3 (2024) |
Isolated head tremor |
Abstract
PDF (Rus)
|
Z. A. Zalyalova, M. M. Ermakova, Z. G. Khayatova |
|
Vol 16, No 3 (2024) |
Cognitive impairment in neuromyelitis optica spectrum disorders |
Abstract
PDF (Rus)
|
E. A. Vekhina, D. S. Kasatkin, S. E. Korchevnyi, K. I. Bereznyak |
|
Vol 16, No 2 (2024) |
Selection of NSAIDs for rational pharmacotherapy of chronic musculoskeletal pain: a clinical pharmacologist's perspective |
Abstract
PDF (Rus)
|
O. I. Butranova, S. K. Zyryanov |
|
Vol 16, No 2 (2024) |
Alzheimer's disease: diagnosis and treatment, errors in patient management |
Abstract
PDF (Rus)
|
V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina |
|
Vol 16, No 2 (2024) |
Interventional diagnosis and treatment methods of discogenic and musculoskeletal low back pain |
Abstract
PDF (Rus)
|
D. A. Ptashnikov, I. V. Volkov, E. N. Lim, S. G. Normatov, Su Lee Chan |
|
Vol 16, No 2 (2024) |
Affective disorders in patients with epilepsy: primary process or consequence of paroxysmal activity? |
Abstract
PDF (Rus)
|
A. O. Osichkina, E. D. Kasyanov, G. V. Rukavishnikov, N. I. Shova, V. A. Mikhailov, G. E. Mazo |
|
Vol 16, No 2 (2024) |
Modelling long-term outcomes and mortality risk in patients with post-stroke spasticity during abobotulinum toxin injections as part of rehabilitation |
Abstract
PDF (Rus)
|
S. E. Khatkova, A. S. Gilweg |
|
Vol 16, No 2 (2024) |
Functional anatomy of the limbic system structures involved in the development of post-traumatic stress disorder: analysis of anatomical and clinical studies |
Abstract
PDF (Rus)
|
V. N. Nikolenko, A. S. Osadchiy, A. K. Lobanova, T. A. Isakova, N. A. Zharov, N. V. Zharova |
|
Vol 16, No 2 (2024) |
Refractory migraine |
Abstract
PDF (Rus)
|
G. R. Tabeeva, O. V. Kosivtsova, N. A. Kovalchuk, T. A. Orlyuk |
|
Vol 16, No 1 (2024) |
Acute cerebrovascular accidents in patients with new coronavirus infection COVID-19 |
Abstract
PDF (Rus)
|
N. A. Shamalov, L. V. Klimov, M. A. Soldatov, T. V. Kiseleva, V. N. Shamalova, N. A. Marskaya, O. V. Lyang |
|
Vol 16, No 1 (2024) |
Neuropsychological assessment of the morphofunctional organization of humour perception processes |
Abstract
PDF (Rus)
|
M. A. Kantova, E. M. Ivanova, Yu. V. Mikadze |
|
Vol 16, No 1 (2024) |
Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A (literature review) |
Abstract
PDF (Rus)
|
A. L. Kurenkov, B. I. Bursagova, A. R. Artemenko |
|
Vol 15, No 6 (2023) |
Neurohumoral gate for the entry of coronavirus into the central nervous system through the cribriform plate of the skull |
Abstract
PDF (Rus)
|
V. N. Nikolenko, M. V. Oganesyan, N. A. Rizaeva, A. T. Nikitina, M. P. Pavliv, А. V. Polyakova, E. A. Sozonova, M. N. Khabibov |
|
Vol 15, No 6 (2023) |
«Gut-brain» axis and multiple sclerosis |
Abstract
PDF (Rus)
|
M. A. Omarova, A. N. Boyko |
|
Vol 15, No 6 (2023) |
Choline alfoscerate in the correction of cognitive impairment |
Abstract
PDF (Rus)
|
O. A. Shavlovskaya, I. D. Romanov, I. A. Bokova |
|
Vol 15, No 6 (2023) |
Neuromyelitis optica spectrum disorders and complement system: issues of pathogenesis and therapeutic options |
Abstract
PDF (Rus)
|
V. S. Krasnov |
|
Vol 15, No 6 (2023) |
Ofatumumab – the first fully human monoclonal antibody approved for the treatment of multiple sclerosis |
Abstract
PDF (Rus)
|
E. V. Popova |
|
Vol 15, No 5 (2023) |
Comparative analysis of the use of selective serotonin reuptake inhibitors during pregnancy and the postpartum period. Safety of sertraline |
Abstract
PDF (Rus)
|
E. A. Ushkalova, A. V. Ushkalova |
|
Vol 15, No 5 (2023) |
Migraine in perimenopausal women |
Abstract
PDF (Rus)
|
D. A. Klimentova, G. R. Tabeeva |
|
Vol 15, No 5 (2023) |
Problems in the selection of effective analgesics for migraine |
Abstract
PDF (Rus)
|
G. R. Tabeeva |
|
Vol 15, No 5 (2023) |
Possibilities of combined use of peptides in the treatment of post-stroke asthenia |
Abstract
PDF (Rus)
|
A. Yu. Emelin, V. Yu. Lobzin |
|
Vol 15, No 5 (2023) |
Depressive disorders and their pharmacotherapy in routine clinical practice |
Abstract
PDF (Rus)
|
S. N. Mosolov, V. A. Parfenov, A. V. Amelin, V. E. Medvedev, V. D. Mendelevich, G. M. Usov, Yu. P. Sivolap, A. N. Bogolepova, E. A. Mkhitaryan, D. S. Petelin |
|
Vol 15, No 5 (2023) |
The phenomenon of “visual snow”: clinical and pathophysiological correlations, differential diagnosis and treatment (literature review) |
Abstract
PDF (Rus)
PDF (Eng)
|
A. S. Kamaeva, E. A. Kiryanova, G. R. Tabeeva |
|
Vol 15, No 5 (2023) |
The role of cellular immunity and systemic inflammation indices in the pathogenetic mechanisms of mental disorders |
Abstract
PDF (Rus)
|
A. P. Gorbunova, G. V. Rukavishnikov, E. D. Kasyanov, G. E. Mazo |
|
Vol 15, No 5 (2023) |
Diagnosis and treatment of depression according to the functional recovery paradigm |
Abstract
PDF (Rus)
|
G. M. Usov |
|
Vol 15, No 5 (2023) |
Vestibular migraine: issues of diagnosis and optimization of therapy |
Abstract
PDF (Rus)
|
O. V. Zaitseva, T. G. Baskova, A. L. Latsinova, O. E. Wenger |
|
Vol 15 (2023): (Suppl. 1) |
Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety |
Abstract
PDF (Rus)
|
A. D. Kukushkina, A. N. Boyko |
|
Vol 15 (2023): (Suppl. 1) |
Neuromyelitis optic spectrum disorders (NMOSD): from pathogenesis to targeted therapy |
Abstract
PDF (Rus)
|
P. A. Zaitseva, A. N. Boyko |
|
Vol 15 (2023): (Suppl. 1) |
The evolution of interferon therapy in multiple sclerosis |
Abstract
PDF (Rus)
|
O. V. Boyko, N. F. Smirnova, A. N. Boyko |
|
Vol 15 (2023): (Suppl. 1) |
Prospects for the use of curcumin as an additional treatment for multiple sclerosis |
Abstract
PDF (Rus)
|
V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko |
|
Vol 15 (2023): (Suppl. 1) |
Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD) |
Abstract
PDF (Rus)
|
T. O. Simaniv, K. Z. Bakhtiyarova, A. N. Belova, Z. A. Goncharova, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, T. N. Trushnikova, E. L. Turova, T. I. Khaibullin, M. A. Sherman, A. N. Boyko |
|
Vol 15, No 4 (2023) |
Endocrine-inactive pituitary tumors: pathology and current approaches to diagnosis and treatment |
Abstract
PDF (Rus)
|
V. N. Nikolenko, B. A. Volel, A. N. Shkarubo, A. A. Nagajtseva, T. S. Zharikova, Yu. O. Zharikov |
|
Vol 15, No 4 (2023) |
Paramagnetic rim sign in multiple sclerosis |
Abstract
PDF (Rus)
|
D. V. Kapkanets, S. E. Belov, M. B. Dolgushin, A. N. Boyko |
|
Vol 15, No 4 (2023) |
The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review) |
Abstract
PDF (Rus)
|
M. A. Kutlubaev, A. R. Rakhmatullin, R. F. Kutlubaeva |
|
Vol 15, No 4 (2023) |
Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity |
Abstract
PDF (Rus)
|
O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova |
|
Vol 15, No 3 (2023) |
Issues of management of patients with post-stroke cognitive impairment |
Abstract
PDF (Rus)
|
A. B. Lokshina, D. A. Grishina |
|
Vol 15, No 3 (2023) |
Vitamin B12 deficiency and Parkinson’s disease |
Abstract
PDF (Rus)
|
Z. A. Zalyalova, E. V. Ekusheva |
|
Vol 15, No 3 (2023) |
Parkinson’s disease. Focus on early stages |
Abstract
PDF (Rus)
|
E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova |
|
Vol 15, No 3 (2023) |
Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies |
Abstract
PDF (Rus)
PDF (Eng)
|
M. Perez, N. N. Zavadenko, L. A. Skipetrova, I. I. Smirnov, Yu. E. Nesterovskiy |
|
Vol 15, No 2 (2023) |
Cognitive disorders in amyotrophic lateral sclerosis |
Abstract
PDF (Rus)
|
M. A. Kutlubaev, D. K. Areprintceva, E. V. Pervushina, L. V. Brylev |
|
Vol 15, No 2 (2023) |
Headache and epilepsy: prevalence and clinical variants |
Abstract
PDF (Rus)
PDF (Eng)
|
V. V. Osipova, A. R. Artemenko, D. A. Shmidt, E. A. Antipenko |
|
Vol 15, No 2 (2023) |
Depression in patients with cerebral microangiopathy |
Abstract
PDF (Rus)
|
A. N. Bogolepova |
|
Vol 15, No 2 (2023) |
Management of patients with chronic cerebrovascular disease |
Abstract
PDF (Rus)
|
Yu. A. Starchina, O. V. Kosivtsova, E. A. Sokolov |
|
Vol 15, No 2 (2023) |
Diagnosis and therapy of obsessive-compulsive spectrum disorders in general medical and neurological practice |
Abstract
PDF (Rus)
|
D. S. Petelin, A. N. Gamirova, O. Yu. Sorokina, D. V. Troshina, S. A. Semin, M. Sh. Boltueva, B. A. Volel |
|
Vol 15, No 2 (2023) |
Vascular cognitive impairment: issues of diagnosis and treatment |
Abstract
PDF (Rus)
|
A. B. Lokshina, D. A. Grishina, V. V. Zakharov |
|
Vol 15, No 2 (2023) |
Efficacy and safety of aceclofenac in musculoskeletal diseases |
Abstract
PDF (Rus)
|
M. A. Isaikina, A. I. Isaikin, L. T. Akhmedzhanova |
|
1 - 70 of 394 Items |
1 2 3 4 5 6 > >>
|